Analysis of effects of bosentan (Ro 47-0203), a nonpeptide endothelin ET_A/ET_B receptor antagonist, in the hind-limb vascular bed of the cat

This publication has 18 references indexed in Scilit:

• Effect of an Endothelin Antagonist on Hemodynamic Responses to Angiotensin II
  Hypertension, 1996
• Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
  The Lancet, 1995
• Effects of the ET_A/ET_B receptor antagonist, bosentan on endothelin‐1‐induced myocardial ischaemia and oedema in the rat
  British Journal of Pharmacology, 1995
• Acute pro‐inflammatory actions of endothelin‐1 in the guinea‐pig lung: involvement of ET_A and ET_B receptors
  British Journal of Pharmacology, 1995
• Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels
  British Journal of Pharmacology, 1995
• Characterization of receptors mediating vascular responses to endothelin‐1 in the conscious rat
  British Journal of Pharmacology, 1994
• Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.
  Hypertension, 1992
• Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.
  Hypertension, 1992
• Differential activities of two distinct endothelin family peptides on ileum and coronary artery
  FEBS Letters, 1989
• The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.
  Proceedings of the National Academy of Sciences, 1989